No abstract available
MeSH terms
- Antineoplastic Agents / therapeutic use
- Bone Marrow Transplantation
- Cytarabine / therapeutic use
- Harringtonines / therapeutic use
- Hematopoietic Stem Cell Transplantation
- Homoharringtonine
- Humans
- Immunologic Factors / therapeutic use
- Interferon-alpha / therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
- Prognosis
- Randomized Controlled Trials as Topic
- Remission Induction
- Risk Factors
- Salvage Therapy
- Treatment Outcome
Substances
- Antineoplastic Agents
- Harringtonines
- Immunologic Factors
- Interferon-alpha
- Cytarabine
- Homoharringtonine